Welcome to our dedicated page for Adapthealth SEC filings (Ticker: AHCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page compiles SEC filings for AdaptHealth Corp. (NASDAQ: AHCO), a company that describes itself as a national provider of patient-centered, healthcare-at-home solutions. Its common stock is registered under Section 12(b) of the Securities Exchange Act of 1934 and trades on The Nasdaq Stock Market LLC under the ticker AHCO, as disclosed in its current reports.
AdaptHealth’s recent regulatory filings include multiple current reports on Form 8-K. These filings furnish press releases announcing quarterly financial results for periods ended June 30 and September 30, along with updates to financial guidance and information on the closing of dispositions of certain assets in its Wellness at Home segment. The 8-Ks also cover a new capitated partnership with a large integrated delivery network and provide details on the company’s annual meeting of stockholders, including votes on director elections, auditor ratification, and advisory approval of executive compensation.
Through these filings, readers can review how AdaptHealth reports net revenue, net income, and cash flow, and how it discusses non-GAAP measures such as EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin, free cash flow, and organic revenue. The company explains in its press releases, furnished as exhibits to the 8-Ks, how these metrics are used in its operational and financial decision-making and how they relate to its credit agreements.
Stock Titan’s SEC filings page presents these AdaptHealth documents with AI-powered summaries that highlight key items, such as earnings announcements, guidance changes, asset sales, and partnership disclosures. Users can quickly locate 8-Ks and related exhibits, and track how the company communicates material events, capital structure developments, and governance matters through the EDGAR system.
AdaptHealth Corp (AHCO) filed a Form 3 Initial Statement of Beneficial Ownership for Daniel Edward McFadden, who has been appointed as the company's Chief Business Systems Officer. The filing, dated June 28, 2025, discloses McFadden's initial beneficial ownership position in the company.
Key ownership details:
- McFadden beneficially owns 53,958 shares of common stock in the form of restricted stock units (RSUs)
- The ownership is held directly (D)
- The RSUs will be settled in common stock upon vesting
The filing was executed by Richard Rew as attorney-in-fact for Daniel McFadden on June 26, 2025. This Form 3 filing is required under Section 16(a) of the Securities Exchange Act of 1934 for new officers, directors, or beneficial owners of more than 10% of a company's securities.
AdaptHealth Corp (NASDAQ: AHCO) has filed Amendment No. 1 to its 2024 Annual Report (Form 10-K/A) to address an omission in the original filing regarding equity compensation plan information. The amendment specifically updates Part III, Item 12 to include the previously omitted Equity Compensation Plan Table.
Key equity compensation details as of December 31, 2024:
- 5,115,684 securities to be issued under the A&R 2019 Stock Incentive Plan with weighted-average exercise price of $9.67
- 9,138,317 securities remaining available for future issuance under the A&R 2019 Plan
- 622,398 shares available under the 2019 Employee Stock Purchase Plan
- 782,991 securities granted to CEO Suzanne Foster as employment inducement outside the approved plans
The company is classified as a large accelerated filer with a market value of approximately $1.07 billion for non-affiliate shares as of June 28, 2024. As of February 21, 2025, AdaptHealth had 134,867,011 shares of Common Stock outstanding.